Imagine losing your visual connection to the world
Imagine your independence slipping away

Age-related macular degeneration is the leading cause of blindness in older adults
Imagine having difficulty reading bedtime stories to your children

Diabetic retinopathy is the leading cause of blindness in working-age adults
At Kodiak we are helping to improve millions of lives

Kodiak is designing and developing novel therapies for the treatment of retinal diseases

Latest News

Kodiak Sciences Announces Closing of $317.4 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Kodiak Sciences Announces Pricing of $276.0 Million Public Offering of Common Stock
Kodiak Sciences Announces Proposed Offering of Common Stock

ABC PLATFORM

At Kodiak, we are developing disruptive products and platforms to prevent and treat the leading causes of blindness

Monospecific
1 Molecule, 1 Target

Bispecific
1 Molecule, 2 Targets

Triplet
1 Molecule, 3 Targets

Our Pipeline

We are committed to progressing and expanding our pipeline towards the prevention, treatment and, when possible, the cure of high-prevalence ophthalmology diseases